This policy watch explains the Medicaid prescription drug rebate cap, examines how many drugs might be impacted, and explores the implications of recent manufacturer responses for Medicaid programs and enrollees.
from KFF https://ift.tt/riqdQp3
from KFF https://ift.tt/riqdQp3
Comments :
Post a Comment